J & J to emphasize cancer drugs, stop much of its vaccine research

J&J to emphasize cancer drugs and stop much of its vaccine research Eight months into his tenure, Johnson & Johnson’s R&D chief is putting a big emphasis on medicines for cancer, treatment-resistant depression, and autoimmune disease. To sharpen that focus, R&D chief John Reed told STAT that the…#johnsonjohnsons #johnreed #stat
Source: Reuters: Health - Category: Consumer Health News Source Type: news